|
Sure would be nice to get an update on the MTfp-TZM program
|
2
|
BIOASIS TECHNOLOGIES INC
|
Feb 11, 2016 11:02PM
|
|
Re: Upcoming CVOT results
|
2
|
Resverlogix Corp.
|
Apr 12, 2019 10:44AM
|
|
Re: Zenith
|
2
|
Resverlogix Corp.
|
Nov 04, 2019 12:45PM
|
|
Bioasis to Host Annual General Meeting Webcast on December 5, 2019
|
2
|
BIOASIS TECHNOLOGIES INC
|
Nov 27, 2019 11:17PM
|
|
Re: Things are happening
|
2
|
Resverlogix Corp.
|
Aug 02, 2018 10:33AM
|
|
Resverlogix Announces Eighth Positive Data Safety Monitoring Board Recommendation For Phase 3 Study of Apabetalone
|
2
|
Resverlogix Corp.
|
Dec 19, 2018 08:53AM
|
|
Re: Wikipedia on Investor Relations: Goal is Fair Valuation
|
2
|
Zenith Epigenetics
|
May 27, 2016 11:37AM
|
|
Re: New Docs
|
2
|
BIOASIS TECHNOLOGIES INC
|
Jul 31, 2016 02:30PM
|
|
Re: 0.05 P-values -- A bridge too far ?
|
2
|
Resverlogix Corp.
|
Feb 14, 2020 01:33PM
|
|
Re: "57% relative risk reduction of MACE in patients with diabetes mellitus (DM) and CVD..."
|
2
|
Resverlogix Corp.
|
Aug 13, 2018 10:20PM
|
|
ROTH conference March 13-16
|
2
|
Resverlogix Corp.
|
Mar 10, 2016 01:23PM
|
|
Re: AACR
|
2
|
Zenith Epigenetics
|
Apr 01, 2019 02:39PM
|
|
Re: PAH Plans get a write up in Pulmonary Hypertension News
|
2
|
Resverlogix Corp.
|
May 21, 2019 10:04AM
|
|
Re: Statistically proven...
|
2
|
Resverlogix Corp.
|
Sep 13, 2019 02:04PM
|
|
Re: AGM time and predictions for SP and Volume tomorrow?
|
2
|
Resverlogix Corp.
|
Sep 29, 2015 10:02PM
|
|
Re: Future Trials
|
2
|
Resverlogix Corp.
|
Feb 14, 2020 01:36PM
|
|
Re: Could there be another shoe waiting to drop?
|
2
|
Resverlogix Corp.
|
May 21, 2019 10:13AM
|
|
Re: ZEN-3694 level up
|
2
|
Zenith Epigenetics
|
Oct 06, 2016 10:10AM
|
|
Re: Near Final Draft of Checklist for Management - A Few More Spelling changes
|
2
|
Resverlogix Corp.
|
Jul 27, 2016 04:18PM
|
|
Re: Clarification on BETonMACE baseline data
|
2
|
Resverlogix Corp.
|
Sep 04, 2019 03:58PM
|
